Trial · NCT01831804
Results by group197
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 197
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | Placebo HVT (Cohort 1) | AEs | 2 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | A/B (Cohort 1) | AEs | 3 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | Placebo DFU SD (Cohort 2, 3, 4) | AEs | 1 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | C (Cohort 2) | AEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | D (Cohort 3) | AEs | 2 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | E (Cohort 4) | AEs | 1 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | Placebo HVT (Cohort 1) | SAEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | A/B (Cohort 1) | SAEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | Placebo DFU SD (Cohort 2, 3, 4) | SAEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | C (Cohort 2) | SAEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | D (Cohort 3) | SAEs | 0 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) Following Single Dose Administration (Part A) | E (Cohort 4) | SAEs | 1 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | Placebo DFU RD (Cohort 5) | AEs | 2 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | R1r (Cohort 5) | AEs | 5 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | Sr (Cohort 5) | AEs | 2 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | Placebo DFU RD (Cohort 5) | SAEs | 1 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | R1r (Cohort 5) | SAEs | 0 | Participants | |
| Number of Participants With AEs and SAEs Following Repeat Dose Administration (Part B) | Sr (Cohort 5) | SAEs | 1 | Participants | |
| Number of Participants With Clinically Significant 12-lead Electrocardiograms (ECGs) Measurement Following Single Dose Administrations (Part A) | Placebo HVT (Cohort 1) | 0 | Participants | ||
| Number of Participants With Clinically Significant 12-lead Electrocardiograms (ECGs) Measurement Following Single Dose Administrations (Part A) | Placebo DFU SD (Cohort 2, 3, 4) | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01831804/results